Sensei Biotherapeutics Inc (SNSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SNSE | AZN | AMGN | GILD | VRTX |
| Company | Sensei Biotherapeutics Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 11.42 | 95.14 | 328.47 | 120.58 | 461.07 |
| High | 11.74 | 95.18 | 328.47 | 124.48 | 464.59 |
| Low | 11.23 | 93.41 | 322.74 | 119.63 | 454.54 |
| Latest | 11.42 | 93.63 | 325.54 | 122.60 | 460.59 |
| Change | -0.19 | -1.02 | -0.56 | +1.50 | -3.27 |
| % Change | -1.68% | -1.08% | -0.17% | +1.24% | -0.70% |
| Volume | 30,400 | 10,755,399 | 2,460,600 | 7,397,000 | 1,350,700 |
| 20-Day Average Volume | 77,675 | 5,009,935 | 2,776,730 | 6,465,170 | 1,365,025 |
| Previous Close | 11.61 | 94.65 | 326.10 | 121.10 | 463.86 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 9.60 | 92.29 | 328.25 | 122.33 | 458.78 |
| 20-Day Raw Stochastic | 91.84% | 60.17% | 37.15% | 54.32% | 39.35% |
| 20-Day Relative Strength | 59.09 | 58.35 | 49.67 | 50.59 | 54.93 |
| Weighted Alpha | +29.89 | +42.80 | +19.59 | +28.86 | +10.60 |
| Today's Opinion | 88% Buy | 100% Buy | 64% Buy | 56% Buy | 88% Buy |
| Previous Opinion | 88% Buy | 100% Buy | 64% Buy | 40% Buy | 88% Buy |
| Last Month's Opinion | 8% Buy | 100% Buy | 72% Buy | 72% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +17.37% since 01/05/26 | +2.64% since 01/05/26 | +1.50% since 01/05/26 | +3.63% since 01/05/26 | +2.63% since 01/05/26 |
| Low | 9.30 on 01/06/26 | 92.46 on 01/06/26 | 318.83 on 01/06/26 | 118.22 on 01/06/26 | 453.69 on 01/06/26 |
| High | 11.74 on 01/12/26 | 96.51 on 01/07/26 | 343.05 on 01/07/26 | 125.11 on 01/08/26 | 487.52 on 01/07/26 |
| 1-Month | |||||
| %Chg | +33.57% since 12/12/25 | +4.23% since 12/12/25 | +2.45% since 12/12/25 | +1.83% since 12/12/25 | +1.89% since 12/12/25 |
| Low | 7.82 on 12/15/25 | 89.53 on 01/05/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 443.12 on 01/05/26 |
| High | 11.74 on 01/12/26 | 96.51 on 01/07/26 | 343.05 on 01/07/26 | 127.41 on 12/23/25 | 487.52 on 01/07/26 |
| 3-Month | |||||
| %Chg | +1.42% since 10/10/25 | +10.77% since 10/10/25 | +12.20% since 10/10/25 | +4.63% since 10/10/25 | +12.95% since 10/10/25 |
| Low | 7.45 on 12/05/25 | 80.48 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 402.58 on 10/13/25 |
| High | 18.35 on 10/16/25 | 96.51 on 01/07/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 487.52 on 01/07/26 |
| 6-Month | |||||
| %Chg | +39.86% since 07/11/25 | +31.63% since 07/11/25 | +10.25% since 07/11/25 | +11.82% since 07/11/25 | -1.76% since 07/11/25 |
| Low | 6.32 on 07/29/25 | 68.61 on 07/21/25 | 269.77 on 09/26/25 | 107.75 on 07/21/25 | 362.50 on 08/11/25 |
| High | 18.35 on 10/16/25 | 96.51 on 01/07/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 487.52 on 01/07/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 14,404 | 290,388,928 | 175,297,120 | 152,107,376 | 116,860,432 |
| Shares Outstanding, K | 1,261 | 3,101,452 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -30,160,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -4,570,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 0.28 | 0.34 | 0.45 | 0.33 | 0.31 |
| Per-Share Information | |||||
| Most Recent Earnings | -3.62 on 11/14/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 03/27/26 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.71 | 14.91 | 14.79 | 30.30 |